- Report
- October 2025
- 204 Pages
Global
From €5204EUR$5,850USD£4,521GBP
- Report
- October 2025
- 361 Pages
Global
From €5204EUR$5,850USD£4,521GBP
- Report
- October 2025
- 384 Pages
Global
From €5204EUR$5,850USD£4,521GBP
- Report
- October 2025
- 144 Pages
Global
From €5204EUR$5,850USD£4,521GBP
- Report
- October 2025
- 149 Pages
Global
From €5204EUR$5,850USD£4,521GBP
- Report
- October 2025
- 194 Pages
Global
From €5204EUR$5,850USD£4,521GBP
- Report
- October 2025
- 196 Pages
Global
From €5204EUR$5,850USD£4,521GBP
- Report
- October 2025
- 307 Pages
Global
From €5204EUR$5,850USD£4,521GBP
- Report
- October 2025
- 154 Pages
Global
From €5204EUR$5,850USD£4,521GBP
- Report
- October 2025
- 183 Pages
Global
From €5204EUR$5,850USD£4,521GBP
- Report
- October 2025
- 178 Pages
Global
From €5204EUR$5,850USD£4,521GBP
- Report
- August 2025
- 199 Pages
Global
From €3153EUR$3,545USD£2,740GBP
€3504EUR$3,939USD£3,044GBP
- Report
- August 2025
- 191 Pages
Global
From €3153EUR$3,545USD£2,740GBP
€3504EUR$3,939USD£3,044GBP
- Report
- August 2025
- 193 Pages
Global
From €3153EUR$3,545USD£2,740GBP
€3504EUR$3,939USD£3,044GBP
- Report
- October 2025
- 250 Pages
Global
From €3994EUR$4,490USD£3,470GBP
- Report
- October 2025
- 250 Pages
Global
From €3994EUR$4,490USD£3,470GBP
- Report
- September 2025
- 250 Pages
Global
From €3994EUR$4,490USD£3,470GBP
- Report
- September 2025
- 250 Pages
Global
From €3994EUR$4,490USD£3,470GBP
- Report
- September 2025
- 250 Pages
Global
From €3994EUR$4,490USD£3,470GBP
- Report
- July 2025
- 175 Pages
Global
From €3994EUR$4,490USD£3,470GBP

Age-related Macular Degeneration (AMD) is a degenerative eye condition that affects the macula, the part of the eye responsible for central vision. It is the leading cause of vision loss in people over the age of 50. AMD is a major concern for the optical industry, as it can lead to severe vision impairment and blindness.
Optical companies are developing treatments and technologies to help diagnose and manage AMD. These include optical coherence tomography (OCT) imaging, which can detect early signs of AMD, and anti-VEGF drugs, which can slow the progression of the disease. Additionally, companies are developing new lenses and other optical devices to help improve vision in those with AMD.
Companies in the AMD market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more